Day: May 16, 2018

U.S. Intervenes in ‘Whistleblower’ Lawsuits Alleging Insys Therapeutics Paid Illegal Kickbacks to Promote Subsys

LOS ANGELES – The United States has intervened in five “whistleblower” lawsuits that accuse Insys Therapeutics, Inc. of paying illegal kickbacks and defrauding federal health programs in connection with the marketing of Subsys, an opioid painkiller manufactured and sold by the Arizona-based company, the Department of Justice announced today.

Scroll to Top